
Camden Residents Weigh In on Psychedelic Therapy: Jeff Brown
Jeff Brown of the Camden Coalition says community input should guide psychedelic-assisted therapy rollout, including Medicaid access and safety.
A community-driven rollout of psychedelic-assisted therapy should begin with listening to residents, according to Jeff Brown, president and chief strategy officer at the
What Camden Residents Said
In September, the Camden Coalition held a town hall in Camden, New Jersey, to educate residents on the state’s research pilots and hear community views. Brown said residents were divided, with some supportive and others questioning the research and efficacy.
Residents asked that care models honor spirituality, culture, and lived experience. Brown noted that some compounds are considered sacred in certain cultures. Residents also called for equitable access across Medicaid, Medicare, and commercial insurance, plus transportation, child care, and language access.
Participants wanted plain-language evidence on effectiveness, dosing, and risk, along with trained facilitators and clear plans for before and after treatment. Citing past institutional harms in some health care access programs, residents asked for community input in site selection and shared decision-making.
Residents preferred peaceful, private settings free of judgment. They saw the most promise for depression, post-traumatic stress disorder, and trauma, and also for opioid and substance use disorders.
Where the Treatment Pathway Stands
Brown said several drugs are in phase 3 trials, and some have breakthrough therapy designation. Intramuscular or IV ketamine and esketamine (Spravato), which some consider part of this class, are already available. Esketamine is FDA-approved, and clinicians in New Jersey offer it.
Brown said a research base is important to support access and define good care as Medicaid coverage develops. New Jersey is setting up 3 state-funded research pilots, and the coalition hopes its community engagement work, supported by the Scattergood Foundation, will inform pilot development, particularly a Medicaid-focused pilot.
Related to this article








